TNF-α and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica

[1]  A. Argyriou,et al.  Neuromyelitis optica: a distinct demyelinating disease of the central nervous system , 2008, Acta neurologica Scandinavica.

[2]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[3]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[4]  F. Molina-Holgado,et al.  Endotoxin preconditioning protects neurones from in vitro ischemia: Role of endogenous IL-1β and TNF-α , 2006, Journal of Neuroimmunology.

[5]  P. Carrieri,et al.  Interleukin-10 and tumor necrosis factor-alpha: model of immunomodulation in multiple sclerosis , 2006, Neurological research.

[6]  S. Rivest,et al.  Tumor Necrosis Factor α But Not Interleukin 1β Mediates Neuroprotection in Response to Acute Nitric Oxide Excitotoxicity , 2006, The Journal of Neuroscience.

[7]  M. Pickering,et al.  Actions of TNF‐α on glutamatergic synaptic transmission in the central nervous system , 2005 .

[8]  M Ruggieri,et al.  Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment , 2005, Multiple sclerosis.

[9]  O. S. León-Fernández,et al.  Oxidized proteins and their contribution to redox homeostasis , 2005, Redox report : communications in free radical research.

[10]  D. Butterfield,et al.  Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia , 2005, Journal of the Neurological Sciences.

[11]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[12]  J. Correale,et al.  The neuroprotective role of inflammation in nervous system Injuries , 2004, Journal of Neurology.

[13]  Daniel Offen,et al.  The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy , 2004, Journal of Neurology.

[14]  P. Kidd.  Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[15]  F. Finkelman,et al.  In Vivo Neutralization of TNF-α Promotes Humoral Autoimmunity by Preventing the Induction of CTL1 , 2001, The Journal of Immunology.

[16]  W. Robinson,et al.  Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? , 2001, Arthritis and rheumatism.

[17]  R. Mandler,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica. , 2001, Brain : a journal of neurology.

[18]  George Kollias,et al.  Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level , 2001, The Journal of experimental medicine.

[19]  M. Feldmann,et al.  Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. , 2000, Arthritis and rheumatism.

[20]  M. Woodroofe,et al.  Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro , 1999, Glia.

[21]  J. Hallenbeck,et al.  Dual role of tumor necrosis factor alpha in brain injury. , 1999, Cytokine & growth factor reviews.

[22]  Link,et al.  Multiple Sclerosis: Levels of Interleukin‐10‐Secreting Blood Mononuclear Cells are Low in Untreated Patients but Augmented During Interferon‐β‐1b Treatment , 1999, Scandinavian journal of immunology.

[23]  Kenneth J. Smith,et al.  Demyelination: The Role of Reactive Oxygen and Nitrogen Species , 1999, Brain pathology.

[24]  P. Jungers,et al.  Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.

[25]  G. Dryhurst,et al.  Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders. , 1998, Chemical research in toxicology.

[26]  M. Uysal,et al.  Peroxidation Potential and Antioxidant Activity of Serum in Patients with Diabetes Mellitus and Myocard Infarction , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[27]  G. S. Shukla,et al.  Possible role of regional superoxide dismutase activity and lipid peroxide levels in cadmium neurotoxicity: in vivo and in vitro studies in growing rats. , 1987, Life sciences.

[28]  T. Keldoulis.  Politics, ethics and the Royal Australian College of Ophthalmologists. , 1986, Australian and New Zealand journal of ophthalmology.

[29]  F. Molina-Holgado,et al.  Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1beta and TNF-alpha. , 2006, Journal of neuroimmunology.

[30]  S. Rivest,et al.  Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  M. Pickering,et al.  Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. , 2005, Experimental physiology.

[32]  J. R. Kanwar.  Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease. , 2005, Current medicinal chemistry.

[33]  M. Eoli,et al.  Low serum interleukin-10 levels in multiple sclerosis: Further evidence for decreased systemic immunosuppression? , 2004, Journal of Neurology.

[34]  K Suzuki,et al.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. , 2001, Nature neuroscience.

[35]  F. Finkelman,et al.  In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL. , 2001, Journal of immunology.

[36]  G. Wong,et al.  TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination , 1998, Nature Medicine.

[37]  B. Descamps-Latscha,et al.  Microtiter plate assay for phagocyte‐derived Taurine‐chloramines , 1992, Journal of clinical laboratory analysis.

[38]  H. Esterbauer,et al.  Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.